Shireburn Software staff hold fundraising sports event to support the ALIVE Charity Foundation
May 8, 2019
Shireburn Software organised a fundraising staff sports activity in collaboration with the ALIVE Charity Foundation, a local NGO, to contribute towards cancer-related medical research at the University of Malta.
Shireburn’s Social Committee organised a sports event and Shireburn’s own team members participated in a series of running, cycling and tug of war challenges against a donation.
Michael Gafa` from the ALIVE Charity Foundation visited the team and provided more detail to the foundation’s mission and goals, and thanked the Shireburn team for contributing towards this worthy cause.
“Our business is built around people, so we see our role within the community as an integral part of our corporate social responsibility,” said Nathan Farrugia, CEO of Shireburn Software. “Giving to great causes is something we believe in, but more-so taking an active part in initiatives themselves. Two of the most precious resources we have are our time and our health, so partnering with Alive Foundation for us was both valuable and fulfilling”.
Watch the video
So what is ALIVE Charity Foundation all about?
ALIVE Charity Foundation was the first charity foundation to raise funds for medical research in Malta whose main aim is to help fight cancer by funding human research and increasing health awareness. In this way, one can speed up diagnosis, identify causes and eventually identify cures. This is why the foundation’s aim has always been to fund Ph.D scholarships at the University of Malta.
ALIVE organises philanthropic activities in order to collect donations to support cancer research through the ALIVE Research Programme. The major event in the foundation’s calendar is the RE/MAX Alive Cycling Challenge for Cancer. The 2019 edition will see a group of 30 cyclists will be cycling over 1,200km from Oslo to Amsterdam passing through several cities in Denmark and Germany. The aim behind this challenge is to raise necessary funds which will be used by researchers working in the field of cancer in Malta.